CCR2 and melanoma: Furthermore, Zhang et al. demonstrated that Toll-like receptors 7 and 8 expression correlated with the expression of immune biomarkers (CCR2, CCR5, CCL3, and CCL5) and positively predicted the clinical outcome of cases with melanoma [29].